Results 81 to 90 of about 12,265 (153)

Real-world cost evaluation of conbercept vs. ranibizumab for retinal and choroidal vascular diseases from 2021 to 2024: evidence from societal and medical insurance perspectives. [PDF]

BMC Public Health
Liu Y, Zhao J, Huang J, Qin Y, Huang Y, Fan H, Zhou W, Han H, You C, Cui Z, Belfort Junior R, Fernandes RAB, Yan H.   +12 more
europepmc   +1 more source

Peep into anti-vascular endothelial growth factor. [PDF]

Indian J Ophthalmol
Verma L, Singh S, Ramachandran O.
europepmc   +1 more source

Efficacy and safety of ranibizumab, aflibercept, and conbercept in the treatment of diabetic macular edema: a retrospective comparative study. [PDF]

Sci Rep
Liu B, Qiao Q, Dang Y.
europepmc   +1 more source

Efficacy and Safety of Ranibizumab Combined with Dexamethasone Intravitreal Implant Sequential Therapy for Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusion. [PDF]

Drug Des Devel Ther
Gao L, Cai X, Dang Y.
europepmc   +1 more source

Synergistic inhibition of macular vascular permeability in diabetic edema: Ginsenoside Rg3 enhances ranibizumab efficacy by targeting angiopoietin-like protein 4 and vascular endothelial growth factor via neuropilin/RhoA signaling. [PDF]

J Diabetes Investig
Yu J, Li X, Liu Y.
europepmc   +1 more source

Retinal vein occlusion-related macular edema: An updated review of current evidence and future directions. [PDF]

Indian J Ophthalmol
Temkar S, Rajasekar G, Shah AD, Shaikh N, Deb AK, Basa K.   +5 more
europepmc   +1 more source

Association of vitreous CREG1 with diabetic macular edema response and edema resolution following ranibizumab therapy. [PDF]

Front Med (Lausanne)
Zhu L, Ding D, Xiao H, Cao Y, Li D, Cao G.   +5 more
europepmc   +1 more source

Efficacy of brolucizumab and ranibizumab in diabetic macular edema and neovascular age-related macular degeneration: insights from a case series. [PDF]

Ann Med Surg (Lond)
Hossain B, Rahmatullah S, Ahmed T.
europepmc   +1 more source

Long-Term Management of Polypoidal Choroidal Vasculopathy: A Narrative Review. [PDF]

Ophthalmol Ther
Koh A, Staurenghi G, Chhablani J, Panos GD, Tan CS, Yamaguchi TCN, Empeslidis T.   +6 more
europepmc   +1 more source

Baseline predictors of visual response and treatment burden after ranibizumab therapy in macular edema secondary to retinal vein occlusion. [PDF]

Front Med (Lausanne)
Li X, Yang L, Long H, Li X.
europepmc   +1 more source